Notice of Intent for Pathology Service for the Washington DC VA Medical Center

The Department of Veterans Affairs (VA), specifically the Network Contracting Office (NCO) 05 located in Baltimore, Maryland, has issued a Special Notice of Intent regarding pathology services for the Washington DC VA Medical Center. The notice announces the VA's plan to award a sole source contract to Nephropathology Associates, doing business as Arkana Laboratories. This contract will be awarded under specific federal acquisition regulations, specifically FAR 13.106-1(b)(1), which allows for a single source procurement when no other suppliers or services can satisfy the agency's requirements. The notice was posted on December 9, 2024, with a response deadline of December 13, 2024, and is specifically focused on securing renal pathology services for the medical center. The procurement falls under the Medical Laboratories NAICS category (621511) with a size standard of $41.5 million.

The primary objective of this Special Notice is to inform potential contractors about the VA's intent to award a sole source contract to Arkana Laboratories for specialized renal pathology services. The notice emphasizes that it is for informational purposes only and does not constitute a competitive solicitation for quotes or proposals. Contractors should note that no solicitation documents will be available, and the VA will not reimburse any costs incurred by parties responding to the notice. Eligibility is effectively limited to Arkana Laboratories, as the procurement is being pursued under a sole source justification per 41 USC 3304(a)(1). The contract will be a Firm Fixed Price arrangement, and interested parties are restricted from submitting competitive responses. The procurement is specifically targeted at obtaining critical pathology services for the Washington DC VA Medical Center, highlighting the VA's focused approach to meeting specific healthcare diagnostic needs.